Please be aware that this site uses cookies
More information

Dr. Nick Perry: Audit of LBI Activity and Possibilities of Tailoring Breast Screening for Individual Women

Clinical Audit

During 2008 we have fully implemented the top European QT data base system, on which all our breast cancers are registered. Our mammography systems continue to be state of the art with the latest digital technology and computer aided detection applied to all our images. First in the UK to install the technology, we estimate that we will be performing our 50,000th digital mammogram in early 2009. First in Europe to use the Suros Vacuum Assisted Core Biopsy Device, we have now carried out over 200 procedures with excellent results. Our image guided Core Biopsy audit shows complete sensitivity of 100% against UK target figures of 85-95%. In 2007 we diagnosed 177 women with breast cancer and this year we estimate 190. This is comfortably in excess of European requirements for a Specialist Breast Unit and very rare in the independent sector. Over the last 5 years, 40% of our breast cancers have been detected in women under the age of 50. 57% of 43-50 year old women with breast cancer had not had a previous mammogram.


Since its launch last year the London Breast Institute has published 10 international academic papers. The most notable success was the press conference awarded to our breast density research paper in Chicago in December 2007 which received blanket TV, radio and media coverage in the United States, a featured slot on Voice of America and an estimated global audience of 350 million.

Density & Screening

Issues of age of patient, breast density and risk, and accuracy of diagnosis are foremost in our minds. Accordingly we are proud to be the first unit in the UK to install the Quantra Automated Density Reader System which provides a computed breast density figure for all women having a mammogram. Breast density is one of the most easily quantifiable risk factors for breast cancer. Increased density however also causes difficulty in cancer detection mammographically. The ideal would therefore be to provide 3 dimensional enhanced diagnostic digital mammographic techniques for all women at increased risk due to high breast density and difficult mammographic patterns. It is our intention to be the first unit in the UK to provide 3 dimensional digital mammography by the end of this year.